You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-MET (MET) Antibodies

Full name:
anti-Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Antibodies (MET)
On are 0 Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) Antibodies from different suppliers available. Additionally we are shipping MET Kits (1) and many more products for this protein. A total of 1 MET products are currently listed.
list all antibodies Gene Name GeneID UniProt
Anti-Rat MET MET 24553 P97523
Anti-Human MET MET 4233 P08581

Show all synonyms

More Antibodies against MET Interaction Partners

Human Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. Transfection of miR (show MLXIP Antibodies)-182 into retinal pigment epithelial (RPE (show RPE Antibodies)) cells induced c-Met downregulation, which led to reduced cell proliferation and migration through declines in p-Akt (show AKT1 Antibodies) formation. MiR (show MLXIP Antibodies)-182 downregulation along with c-Met upregulation in proliferative vitreoretinopathy (PVR (show PVR Antibodies)) tissues suggest that these two opposing effects play important roles in PVR (show PVR Antibodies) development.

  2. Either upregulating miR (show MLXIP Antibodies)-182 in retinal pigment epithelial cells or downregulating c-Met expression reduced HGF/SF (show HGF Antibodies)-induced rises in both retinal pigment epithelial cells proliferation and chemotaxis through declines in Akt (show AKT1 Antibodies) activation.

  3. his review will describe the mechanisms of aberrant c-Met signaling in colorectal cancer and discuss on additional roles for c-Met receptor through crosstalk with other tyrosine kinase (show TXK Antibodies) receptors and cell surface proteins in colorectal cancer

  4. This article reviews aberrations in epidermal growth factor receptor (show EGFR Antibodies), MET, and ERBB2 (show ERBB2 Antibodies), their therapeutic implications, and future directions in targeting these pathways.

  5. This review highlights treatment options, including clinical trials for ROS1 rearrangement, RET fusions, NTRK1 fusions, MET exon skipping, BRAF mutations, and KRAS mutations.

  6. MET amplification and overexpression, assessed by multiple methods, were associated with a worse prognosis in univariate analyses. However, only MET amplification by FISH and Met expression by SRM (show SRM Antibodies) were independent prognostic biomarkers.

  7. AZD9291 is the first and only FDA approved third-generation epidermal growth factor receptor (EGFR (show EGFR Antibodies)) tyrosine kinase (show TXK Antibodies) inhibitors for T790M-positive advanced non-small cell patients. The resistance to AZD9291 arises after therapy. The mechanisms of resistance to third-generation inhibitors reported to date include the EGFR (show EGFR Antibodies) C797S mutation, EGFR (show EGFR Antibodies) L718Q mutation, and amplifications of HER-2 (show ERBB2 Antibodies), MET, or ERBB2 (show ERBB2 Antibodies). [review]

  8. study indicates that tyrosine kinase (show TXK Antibodies) signaling in host pre-osteoclasts/osteoclasts is critical for bone destruction induced by tumor cells and that targeting of MET/VEGF receptor (show FLT1 Antibodies)/FMS (show CSF1R Antibodies) activity makes it a promising therapeutic candidate for the treatment of prostate cancer patients with bone metastasis.

  9. Data identify, for the first time, a novel non-canonical dynamic mode of interaction between Met and the p66 (show POLD3 Antibodies) protein isoform of Shc (show SHC1 Antibodies) and its effects on rewiring binding effector complexes according to the activation state of the receptor.

  10. Specifically, miR (show MLXIP Antibodies)-130a was attenuated in HFD-induced PCa (show FLVCR1 Antibodies) progression with MET overexpression. miRNAs thus have implications in the mechanism, prevention and treatment of HFD-induced prostate cancer (PCa (show FLVCR1 Antibodies))progression.

Cow (Bovine) Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF Antibodies) and HGF (show HGF Antibodies) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (hepatocyte growth factor receptor) (MET) antibody
  • met proto-oncogene (Met) antibody
  • met proto-oncogene (MET) antibody
  • hepatocyte growth factor (hepapoietin A; scatter factor) (HGF) antibody
  • hepatocyte growth factor (HGF) antibody
  • hepatoCyte growth factor receptor (Tsp_05936) antibody
  • AUTS9 antibody
  • c-met antibody
  • HGF antibody
  • HGFR antibody
  • MET antibody
  • RCCP2 antibody

Protein level used designations for MET

HGF receptor , HGF/SF receptor , SF receptor , c-Met , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , HGF receptor c-Met , hepatocyte growth factor , hepatoCyte growth factor receptor , met proto-oncogene , Hepatocyte growth factor receptor , hepatocyte growth factor receptor-like , Proto-oncogene c-Met , Scatter factor receptor , Tyrosine-protein kinase Met

100126565 Oryctolagus cuniculus
24553 Rattus norvegicus
4233 Homo sapiens
280855 Bos taurus
403438 Canis lupus familiaris
443075 Ovis aries
463671 Pan troglodytes
493669 Felis catus
708316 Macaca mulatta
10911086 Trichinella spiralis
100126669 Papio anubis
100137030 Pongo abelii
100137502 Ornithorhynchus anatinus
100408551 Callithrix jacchus
Did you look for something else?